Original Source(s)
Related Content
FDA expands gastroesophageal cancer options
Phase 3 findings showed longer median progression-free survival with zanidatamab-containing regimens vs trastuzumab plus chemotherapy.
August 25, 2026
-
2 min
Muscle recovery following knee arthroplasty
Investigators assessed changes in quadriceps and hamstring strength and flexibility through 12 months following total knee arthroplasty.
September 23, 2026
-
3 min
Incidence of flatfoot after peroneuslongus ACL grafting
Investigators found few cases of postoperative arch collapse, but alternative footprint measurements classified substantially more cases of flatfoot.
November 4, 2026
-
4 min